What’s the best test for cervical cancer? Pap, HPV or both?
In a commentary in this week’s issues of Annals of Internal Medicine, Drs. …
Tag Archives: boston
Marginal life expectancy benefit from contralateral prophylactic mastectomy — ScienceDaily
To assess the survival benefit of CPM, Pamela R. Portschy, of the Department of Surgery, University of Minnesota, Minneapolis, and colleagues, developed a model simulating survival outcomes of CPM or no CPM for women with newly diagnosed stage I or II breast cancer, using data from the Surveillance, Epidemiology, and End Results (SEER) registry and large meta-analyses. Survival benefit projections were made for women by age (40, 50, or 60 years), breast cancer stage (I or II), and estrogen receptor (ER) status (positive or negative). Women with BRCA mutations were excluded from the analysis because they have a much higher risk of developing contralateral breast cancer. …
MRI catches breast cancer early in at-risk survivors of childhood Hodgkin lymphoma — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/05/140528102927.htm
More than two-thirds of healthy Americans are infected with human papilloma viruses — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/05/140520115514.htm
Cancer’s potential on-off switch linked to epigenetics — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/05/140515123305.htm
CT in operating room allows more precise removal of small lung cancers — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/04/140430091416.htm
Gene linked to pediatric kidney cancer suggests new strategies for kidney regeneration — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/04/140413171712.htm
New drug, molecular insight into triple negative breast cancers — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/04/140410194607.htm
Personalized gene therapy locks out HIV, paving the way to control virus without antiretroviral drugs — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/03/140305191158.htm
Mutant-Allele Tumor Heterogeneity (MATH) in head, neck squamous cell carcinoma patients is effective marker, along with HPV status, of improved…
source : http://www.sciencedaily.com/releases/2014/02/140220102601.htm